Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Arkin Capital, founded in 2009 by Mori Arkin, operates as a multi-stage, multi-asset investment manager based in Israel. The firm manages over $2 billion across various investment strategies, including venture capital, private equity, and hedge funds. Initially, Arkin Capital concentrated on life sciences, particularly health technologies, but has since broadened its investment scope to encompass technology and real estate, with a strong commitment to sustainability.
As of now, Arkin Capital oversees a portfolio of nine companies, reflecting its diverse investment approach. The firm has established a significant presence in North America and Europe, focusing on sectors that align with sustainable development goals. Notable milestones include the expansion of its investment areas and the establishment of dedicated divisions such as Arkin Health and Arkin Tech, which target specific market needs.
Arkin Capital employs a multi-faceted investment strategy, targeting various stages from pre-seed to growth equity. The firm invests across several sectors, including healthcare, biotech, digital health, energy, AI, SaaS, fintech, and consumer markets. Arkin Capital's investment strategy is divided into four main areas:
The firm typically invests between $1 million to $20 million per deal, depending on the stage and sector. Arkin Capital seeks founders who demonstrate a commitment to sustainability and innovation, looking for strong teams with a clear vision and market understanding.
Arkin Capital's portfolio includes nine notable companies, showcasing its diverse investment strategy:
This diverse portfolio reflects Arkin Capital's commitment to investing in sustainable technologies across various sectors.
Mori Arkin: Founder & Chairman, with extensive experience in investment management and a focus on health technologies.
Nir Arkin: CEO, leading the firm's strategic direction and operations.
Itai Arkin: Director, Global Capital Markets, specializing in capital market strategies and investments.
Hani Lerman: CFO, overseeing financial operations and strategy.
Yaniv Cohen: Managing Director, with expertise in investment management and portfolio development.
Pini Orbach: Managing Partner, focusing on strategic investments and partnerships.
Adar Makovski Silverstein: Principal, involved in deal sourcing and portfolio management.
Alon Lazarus: Managing Partner, with a background in venture capital and technology investments.
Avital Adlar: Principal, specializing in investment analysis and market research.
Chen Koton: Direct Equity, focusing on equity investments and portfolio strategy.
David Alterman: Principal, involved in investment evaluation and portfolio management.
Nimrod Bar: Managing Director, with expertise in venture capital and growth equity.
Sam Cronin: Partner, focusing on strategic investments and portfolio development.
Startups should pitch to Arkin Capital through their contact form on the website. A well-structured pitch deck should include details on the business model, market opportunity, and sustainability initiatives. Response times may vary, and warm introductions are likely beneficial.
In recent months, Arkin Capital has actively expanded its portfolio, particularly in the health and technology sectors. The firm continues to emphasize its commitment to sustainability and innovation, aligning its investment strategies with sustainable development goals. Notable portfolio additions include companies like Keros Therapeutics and HI-Bio, which focus on health technologies.
Arkin Capital has also been involved in discussions regarding new investment opportunities in renewable energy, reflecting its ongoing focus on sustainability. The firm has not published specific blog posts or articles recently, but updates on their website highlight their strategic direction and commitment to sustainable investing.
What are Arkin Capital's investment criteria?
Arkin Capital invests in early to late-stage companies across multiple sectors, including healthcare, biotech, and technology. The firm looks for startups that demonstrate a commitment to sustainability and innovation, with strong teams and clear market understanding.
How can founders apply or pitch to Arkin Capital?
Founders can reach out to Arkin Capital through their website's contact form. A well-prepared pitch deck that outlines the business model, market opportunity, and sustainability focus is essential for consideration.
What makes Arkin Capital different from other investors?
Arkin Capital emphasizes sustainability in its investment strategy, focusing on sectors that align with sustainable development goals. The firm also provides strategic guidance and access to capital markets, leveraging its extensive network in technology and health sectors.
What is the geographic scope of Arkin Capital's investments?
Arkin Capital primarily invests in North America and Europe, targeting companies that operate within these regions and align with its sustainability goals.
What is the typical fund size and check size for investments?
Arkin Capital manages over $2 billion in assets under management (AUM) and typically invests between $1 million to $20 million per deal, depending on the stage and sector of the company.
What kind of post-investment involvement does Arkin Capital have?
Arkin Capital adds value to its portfolio companies through strategic guidance, operational support, and access to its extensive network. The firm is actively involved in helping companies navigate capital markets and achieve their growth objectives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.